ArticleiScience2024

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine.

Masayuki Aboshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.